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Sevoflurane is a potent anesthetic that is widely used due to its 
efficacy in preventing arrhythmias associated with epinephrine. The 
mechanism of negative inotropic effect of sevoflurane was examined 
in the present study on canine single ventricular myocytes. The 
effects of sevoflurane on contractile response, membrane potential, 
membrane ionic currents and intracellular cyclic AMP were studied. 
Contractions were measured by a video-�edge detector and membrane 
ionic currents were recorded using whole-cell voltage clamp 
technique. Sevoflurane, in concentrations ranging from 1. 0% to 
4. 0%, decreased contraction of single ventricular cells. These 
inhibitory effects on the contractile response were dose-dependant 
and reversible. In normal Tyrode solution, sevoflurane decreased 
the plateau of action potentials and shortened the durations. In 
high-K+ ( 26mM) Tyrode solution, the duration of slow action 
potential was shortened. 
Voltage-clamp experiment with single canine ventricular cells 
3 
revealed that sevoflurane reduced the peak Ca2• currents ( rea). These 
inhibitory effects of sevoflurane on lea did not show use-dependent 
block. On the other hand, sevof 1 urane depressed Na • currents ( INa ) 
only in high concentration (4. 0%) and had no effect on the inward 
rectifier K• currents ( IKl). The inhibition of lea was not associated 
with changes in intracellular concentration of cyclic AMP except at 
a high dose ( 4. 0%). These results suggest that the negative 
inotropic effect of sevoflurane is mediated via inhibition of lea in 
canine ventricular cells. (Key words: Anesthetics, volatile, 
sevoflurane. canine heart; single cell; calcium current; sodium 
current; cyclic AMP) 
4 
Introduction 
Sevoflurane (fluoromethyl 2, 2, 2-trifluoro- 1-[trifluoromethyl] 
ethyl ether, SV) is a rapid-acting, potent, inhalational anesthetic 
and often used clinically today. Rapid uptake and elimination of 
sevoflurane are due to a low blood I gas partition coefficient 
reported to be 0. 61l. Unlike other inhaled anesthetic agents such as 
halothane and isoflurane, SV is much safer in preventing 
arrhythmias due to epinephrine2l and has a lower incidence of 
hepatic toxici ty3l. However, there are reports of circulatory 
depression by SV4-6l. This effect is also observed with halothane and 
isoflurane and could be due to inhibition of intracellular Ca2+ 
release or inhibition of Ca2+ influx. The mechanism by which SV 
produces circulatory depression is not known. Previously, we 
reported that SV-induced inhibition of canine papillary muscle 
contraction may be due to a reduction of plateau and duration of the 
slow action potential7l. However, detailed description of the 
5 
effects of SV on membrane currents are required to better 
understand its pharmacological effect. These studies were carried 
out to examine the effects of SV on contractile responses and 
membrane currents in canine single ventricular cells using whole-
cell voltage clamp. 
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Materials and Methods 
Cell isolation 
Twenty three adult mongrel dogs of either sex weighing 8- 12kg were 
anesthetized with ketamine (25mg/kg, intramuscular inj ection). 
Heparin (5000U) and pentobarbital (20mg/kg) were administered 
intravenously and the chest was opened. Hearts were excised 
immediately, and Tyrode solution (37°C) was perfused via the left 
coronary artery for 15 minutes. [ Tyrode solution contained (in mM) 
NaCl: l35, KC1:4, Na2HP04:0.33, Dextrose:lO, HEPES: lO, MgCl26H20: 1, 
CaCl2: 1.8 (pH 7.4 by NaOH).] Then, calcium free Tyrode solution 
containing 0. 05% collagenase was perfused for 30 minutes. After the 
treatment with the enzyme, left ventricle was minced into small 
pieces and agitated in calcium free Tyrode solution containing 
0. 05% collagenase and 0. 006% trypsin8l until single cells were 
released. The solution was then filtered and single cells 
resuspended in Ca2+-free Tyrode solution. A total of 158 single 
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cells were used in this study. 
Application of sevoflurane 
SV was applied by bubbling 100% oxygen gas into Tyrode solution 
through a SV vaporizer ( Sevotec 3, Ohmeda, West Yorkshire, 
England). The concentration of SV was moni tared by anesthetic gas 
analyzer ( CAPNOMAC, Datax, Helsinki, Finland). All experiments were 
performed at 37°C. 
Effects of SV on contractile response, membrane potential, 
membrane ionic currents and intracellular cyclic AMP concentration 
were studied at SV concentration of 1. 0,. 2. 0 and 4. 0%. Comparisons 
between group data were made with Student's t test for unpaired 
samples and Kruskal-Wallis test was used to determine dose-
dependency. All results are presented as mean+SD. Data were 
evaluated statistically significant at P<0.05. 
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Electrophysiological techniques 
Dispersed cells were placed in a perfusion chamber (37°C) on the 
stage of an inverted microscope ( IMT-2, Olympus, Tokyo, Japan) 
equipped with Nomarski optics. At 600X magnification, a hydraulic 
micromanipulator (M0-103, Narishige, Tokyo, Japan) was used to 
position glass microelectrodes with tip resistances of 3 -5MQ on the 
membranes of single ventricular cells. The pipette solution 
contained (in mM) potassium gluconate:l40, ATP:2, HEPES:5, 
EGTA:0.15 (pH 7.2 by KOH) . In order to maintain the cytoplasmic 
constituents and avoid 'run-down' of Ca2+ currents, the perforated 
patch technique was used91• This technique involves adding the 
antibiotic, nystatin, to the recording pipette. The transmembrane 
pores formed by nystatin allow monovalE�nt ions in the pipette to 
equilibrate with the myoplasm. Large anions and/or molecules cannot 
pass through the nystatin induced pores thus effectively trapping 
them in the cytosol. The resulting lack of 'wash-out' of the 
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cytoplasmic factors appears to prevent the 'run-down' of rca. 
Contraction of single cells was initiated by extracellular field 
stimulation (0.5Hz, 15V, lmsec) . Unloaded cell shortening was 
measured on-line using a video edge detector. A miniature CCD 
camera ( FCD-725, Olympus, Tokyo, Japan) was attached to the camera 
port of the inverting microscope and the output was fed to a video 
edge detector (Crescent Electronics, Sandy, Utah, U.S. A. ) . Records 
of cell shortening were recorded by the digital recording system 
( RP-8 80, NF Electronic Instruments, Yokohama, Japan) . Action 
potentials induced by intracellular stimulation were also recorded 
with the digital recording system. 
Whole-cell voltage clamp technique was employed to measure ionic 
currents by using the patch clamp amplifier (Yale MK-V, New Haven, 
U.S. A. ) 10l. All data were recorded on PCM recording system ( PCM DP16, 
Shoshin EM Corp. , Okazaki, Japan) . 
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Assessment of intracellular cyclic AMP concentration 
Isolated canine ventricular cells were suspended in normal Tyrode 
solution at a density of 1-2mg protein I ml. The protein 
concentration of the suspension was estimated by the method of 
Lowery with bovine serum albumin as the standard11l. SV was vaporized 
by 100% oxygen gas and bubbled into the cell suspension for 10 
minutes. At the end of the period, 450 � 1 of bubbled cell suspension 
was sampled. Then 2 5 � 1 of 2 N HCl and 2 5 � 1 of 1 OOmM EDTA were added 
to the mixture, and the incubation tube was immersed in boiling 
water for 10 minutes to extract cyclic AMP, as described by Hazeki 
and Ui 12l. After a brief centrifugation of the acidified suspension 
at 3000 rpm for 10 minutes, the s�pernatant was subj ect to the 
radioimmunoassay by means of cyclic AMP assay kits (Yamasa Syoyu, 
Chiba, Japan) . The cyclic AMP level was expressed as picomoles per 
milligram of protein. 
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Results 
Previously, we demonstrated the negative inotropic effect of SV 
on multicellular preparation of the isolated canine ventricles7l. 
In this study, we have directly measured the shortening of unloaded 
single cells from canine ventricles. SV dose-dependently decreased 
contractions induced by electrical stimulation in single canine 
ventricular cells (Fig.1, Table 1) . ThE�se depressant effect were 
maximal within 5-7 minutes and recovered to control level in 10-15 
minutes after wash out of SV. 
As shown in figure 2 and presented in table 2, SV did not alter the 
resting membrane potential in normal Tyrode solution. On the other 
hand, SV decreased the plateau height of action potentials (Fig. 2) 
and shortened the duration of action potentials. 30% repolarization 
(from plateau height) was reduced by approximately 377 msec at 2. 0% 
SV. These results suggest that SV is likely to alter Ca2+ 
homeostasis. In order to examine the effE�cts of SV on transmembrane 
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ca2• flux, the cells were bathed in high-K+ ( 26mM) Tyrode solution 
. . 10-6 M conta1n1ng isoproterenol. these conditions, the 
membrane potential was depolarized t:o -40 mV (and therefore 
inactive sodium currents) . SV had no effect on the resting membrane 
potential, however, the duration of the action potential was 
markedly reduced (Fig.3, Table 3) . 
The effects of SV on lea were examined using the whole-cell voltage 
clamp technique. Calcium currents were obtained by applying 
depolarizing pulses from a holding potential of -30mV or -40mV. 
Fig. 4 shows dose-dependent inhibition of peak lea by SV. The 
current-voltage relationship for peak lea is shown in fig.S. The 
amplitude of peak lea was inhibited by SV in a dose-dependent manner. 
lea were measured in the absence of SV with test depolarization once 
every 5 seconds. Depolarization were then discontinued, drug was 
applied, and after a 10 minutes quiescent period, depolarizing test 
pulses were resumed. In this procedure, SV (2. 0%) did not show an 
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use-dependent depression of peak lea in single canine ventricular 
cells (Fig.6) . 
The effects of SV on INa were examined by applying a series of test 
pulses from a holding potential of -70mV to more positive 
potentials. Figure 7 shows the effect of SV on a series of INa 
recordings elicited by test pulses from -80 to -30mV in a single 
canine ventricular cell. INa were decreased only in 4. 0% SV 
(1.0%:98.6+3.1, 2.0%:9 2.6+5.8, 4.0%:85.2+6.3* % of control, n=5, 
*P<0.05) . 
IK1 were measured by stepwise hyperpolarizing pulses from holding 
potential of -70mV to more negative command potentials. The 
experiment illustrated in figure 8 showed no change of IK1• 
In order to examine whether the effects of SV were due to changes 
in cyclic AMP, cyclic AMP levels were measured using 
radioimmunoassay. Table 4 shows that only at 4.0% SV, cyclic AMP 
levels were decreased. 
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Discussion 
The present experiments provide information concerning the 
actions of SV on lea using both electrophysiological and biochemical 
techniques. First, we examined effects of SV on contractile 
responses in single canine ventricular cells. Our results showed 
that contractions of single cells are decreased by SV ( 1.0-4.0%) . 
Subsequently, we studied action of SV on membrane potentials in 
single ventricular cells. Following SV administration, the plateau 
phase and duration of the action potential were significantly 
decreased without change in the resting potential. Moreover, SV 
decreased duration of the slow action potential induced by high-K+ 
( 26mM) Tyrode sol uti on. Slow action potentials recorded from 
partially depolarized myocytes results primarily from the entrance 
of Ca2+ into the cell presumably the L-type of Ca2• channels. These 
results are similar to those of halothane., isoflurane and enflurane 
in multi-cellular preparation13l14l. Recently, Bosnj ak et al reported 
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that both halothane and isoflurane produced a similar degree of 
inhibition of lea elicited by the voltage-clamp studies in single 
guinea pig ventricular cells15l. Our study in the first to show that 
SV produce a concentration-dependent de�pression of peak lea without 
shifting the current-voltage relationship for Ca2+ channel 
activation. Therefore, the negative inotropic effect of SV on the 
myocardium are probably related, at least in part, to the 
depression of lea similar to other inhalational agents16-18l. In 
addition, we found that sevoflurane did not show use-dependent 
block (accentuation of drug inhibition by repetitive membrane 
depolarization) in single cells. These inhibitory blocking 
mechanism of lea are different from thiopental or D600, an organic 
Ca2+ channel blocker. However, these results do not exclude the 
possibility that the inhibitory effects on myocardial contractility 
by SV may be due to affects on Na+ I Ca2+ exchange or intracellular 
Ca2+ stores6l. To define a possible site at: which SV acts, we measured 
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the cyclic AMP concentration of single cells using 
radioimmunoassay. The results show that at concentrations of SV 
that reduce Ica' cyclic AMP levels were not altered. These results 
differ from those in response to halothane19l. IK1, which regulates 
the resting membrane potential, was not significantly modified by 
SV ( 1.0-4.0%) consistent with no changre in the resting membrane 
potential. On the other hand, only high concentration of SV ( 4. 0%) 
significantly reduced INa in single cells. Thus, the depressant 
effect of SV on contractility in cardiac myocardium cannot be 
attribute to inhibition of Na+ channels .. 
In summary, our study indicates that the decrease of myocardial 
contractile response in single canine cardiac cells is related, at 
least in part, to inhibition of rca at the sarcolemma and not through 
changes in intracellular cyclic AMP levels. 
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Fig.1 :2 sec 
Cell shortening traces recorded by extracellular field 
stimulation (0. 5Hz, 1msec, 15V) through Ag-AgCl electrodes in the 
absence (control) ,  in the presence of sevoflurane ( 1%, 2%, 4%) and 
10 minutes after washed off sevoflurane (recovery) in single canine 
ventricular cell. 
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Effects of sevoflurane (2%1 4%) on Ica were examined in single 
ventricular cells. Ica were elicited by depolarizing pulses ( +40mV I 
lOOmsecl 0.2Hz) from a holding potential of -40mV. 
A: Effects of sevoflurane ( 2% I 4%) on rca in single ventricular cell. 
B: The corresponding I-V (current-val tage relations) curves for the 
control and 2%, 4% sevoflurane are shown. These I-V curves were 
plotted as peak inward current or minimum outward currents at each 
command potential. 
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